How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...
People living positive with HIV along the Zambezi Valley are angry with their local health authority over access to drugs. The residents in Kanyemba in Mbire district get their drugs from neighbouring Zambia.
Although health officials say Chapoto Clinic in Kanyemba is capable of starting people on antiretroviral drugs beneficiaries insist on going to Luanga Clinic in Zambia citing better services.
Kanyemba has Chikunda people and a minority Doma community.
Authorities have since approached their Zambian counterparts to stop giving ARVs to HIV-positive people from Zimbabwe.
This is expected to promote use of local services.
National Aids Council District Aids Co-ordinator for Mbire Mr Claudius Musandaira said the exact number of people getting treatment from Zambia was not known.
He, however, said 16 people from a community of about 4 300 people are accessing ARVs at Chapoto Clinic.
Statistics show that one in every four people are living with HIV though it is not everyone requiring ARVs.
Mr Musandaira said 10 of these people were transferred from Zambia.
"We want them to stop getting drugs from Zambia because we are now able to provide them at our local clinic.
"We will continue educating them on the importance of getting drugs locally instead of crossing over to Zambia," he said.
However, one person who receives drugs from Zambia said they are not sure of receiving competent service from Chapoto Clinic.
The patient who lives a stone's throw away from Chapoto Clinic said he will continue sailing across the Zambezi River to access drugs in Zambia.
"Here, the reception is very bad, some of the nurses have an attitude towards patients, drugs are limited and the doctor comes on specific dates.
"There is also no laboratory, all tests except the HIV test are done in Guruve and they take time to be returned but in Luanga everything is done on site," said the patient.
He said even though the distance to a referral hospital from Luanga is as good as going to Harare, they still prefer going to Zambia than going to Guruve because of the good road.
But a primary care nurse manning Chapoto Clinic, Mr Patric Kahuswa, said crossing to Zambia is risky for them for they might be attacked by animals.
He said although some people have accepted to transfer to Chapoto from Luanga still many people continue to shun local services.
"We test them here, but they do not come back for treatment. Once they know they are HIV positive, they quickly cross to Zambia for treatment," Mr Kahuswa said.
He said about 80 people have since tested positive for HIV at the clinic with many cases deserving to immediately commence of ART.
Mr Musandaira said people in Kanyemba are at high risk of contracting HIV compared to people elsewhere in the district because there is a lot of human traffic at the border.
"There is a lot of human traffic at this border with many people coming from Zambia and Mozambique. Sometimes people coming from Tanzania also use this border," he said.
He said with such a scenario cases of sexual favours as payment for services cannot be dismissed.
He appealed for increased resources in the community saying there were very few non-governmental organisations working in the area.
He, however, said the minority Doma people need prevention interventions because HIV prevalence among them is still minimal.
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.